We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Regulatory News (HAYD)

Share Price Information for Haydale (HAYD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.46
Bid: 0.45
Ask: 0.47
Change: 0.005 (1.10%)
Spread: 0.02 (4.444%)
Open: 0.455
High: 0.46
Low: 0.455
Prev. Close: 0.455
HAYD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity and Total Voting Rights

10 Apr 2017 07:00

RNS Number : 9884B
Haydale Graphene Industries PLC
10 April 2017
 

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

 

For immediate release

10 April 2017

 

Haydale Graphene Industries plc

("Haydale", "Group" or the "Company")

 

Issue of Equity and Total Voting Rights

 

Haydale (AIM:HAYD), the global nanomaterials group, announces the issue of 6,500 new ordinary shares of 2 pence each in the Company ("New Shares") pursuant to the exercise of employee options at 92.5926p per share. The New Shares will rank pari passu with the Company's existing Ordinary Shares. Application has been made for the New Shares to be admitted to trading on AIM, with admission expected to occur on or around 12 April 2017 ("Option Shares Admission").

 

Following the Option Shares Admission and the admission of 763,247 new Ordinary Shares pursuant to the Subscription Agreement, as noted in the Company's earlier announcement, the total number of voting rights in the Company will be 19,309,231 Ordinary Shares and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

- Ends -

 

For further information:

Haydale Graphene Industries plc

 

Ray Gibbs, Chief Executive Officer

Tel: +44 (0) 1269 842 946

Matt Wood, Finance Director

www.haydale.com

Trevor Phillips, Head of Communications

 

 

 

Cairn Financial Advisers LLP (Nominated Adviser)

 

Tony Rawlinson / Emma Earl

Tel: +44 (0) 20 7213 0880

 

 

Cantor Fitzgerald Europe (Broker)

 

David Foreman / Will Goode (Corporate Finance)

Tel: +44 (0) 20 7894 7000

David Banks / Mark Westcott (Sales)

 

 

Media enquiries:

Buchanan

 

Henry Harrison-Topham / Jamie Hooper

Tel: +44 (0) 20 7466 5000

haydale@buchanan.uk.com

www.buchanan.uk.com

 

Notes to Editors

Haydale is a global technologies and materials group that facilitates the integration of nanomaterials into the next generation of commercial technologies and industrial materials. With expertise in graphene, silicon carbide and other nanomaterials, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, as well as toughness. Haydale has granted patents for its technologies in Europe, USA and China and operates from four facilities in the UK, USA and the Far East.

 

For more information please visit:

www.haydale.com

Twitter: @haydalegraphene

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKLXEDKXEFF
Date   Source Headline
13th Jun 20189:00 amRNSPrice Monitoring Extension
13th Jun 20187:00 amRNSTrading Statement and Director Resignation
25th May 20187:00 amRNSHaydale Ceramics Technologies
16th Apr 20189:10 amRNSNotification of Major Holdings
1st Mar 20187:00 amRNSInterim Results
19th Feb 20187:00 amRNSSupply Agreement with Graphene Platform Corp
25th Jan 20187:00 amRNSTrading Update
18th Jan 20187:00 amRNSChange of Adviser
17th Jan 20187:00 amRNSCommercial Agreement with Talga Resources
18th Dec 20177:00 amRNSShare options and awards, LTIP and PDMR dealings
12th Dec 201711:25 amRNSResult of AGM
20th Nov 20177:00 amRNSNew Patent Application
20th Nov 20177:00 amRNSAnnual Report & Notice of AGM
1st Nov 20177:00 amRNSPDMR Dealings
31st Oct 20175:48 pmRNSNotification of Major Holdings
30th Oct 20177:00 amRNSGrant of US Patent
27th Oct 201710:45 amRNSResult of General Meeting, Issue of Equity and TVR
26th Oct 201710:06 amRNSResult of Conditional Offer
19th Oct 20171:20 pmRNSCREST Clarification
10th Oct 20174:21 pmRNSClose of Accelerated Bookbuild
10th Oct 20177:00 amRNSProposed Accelerated Bookbuild to raise £6 million
10th Oct 20177:00 amRNSFull Year Results
26th Sep 20177:00 amRNSEverpower places initial orders for Chinese market
11th Sep 20177:00 amRNSChange of Adviser
1st Sep 20177:00 amRNSNew Sales Contract
22nd Aug 20177:00 amRNSAdvanced Composites Proposed Collaboration
9th Aug 20177:00 amRNSLaunch of Taiwan operations
19th Jul 20177:00 amRNSTrading update
13th Jul 20177:00 amRNSAppointment of Chairman
29th Jun 20177:00 amRNSGrant of Options
20th Jun 20177:00 amRNSIssue of Equity and Total Voting Rights
24th May 201711:30 amRNSPDMR Dealing
15th May 20177:00 amRNSAcquisition of HTI Minority Interest
11th May 20177:00 amRNSMemorandum of Understanding with Nanospan India
9th May 20177:00 amRNSIssue of Equity and Total Voting Rights
28th Apr 20177:00 amRNSIssue of Shares
25th Apr 20177:00 amRNSPDMR Dealing
19th Apr 20177:00 amRNSPDMR Dealing
10th Apr 20177:00 amRNSIssue of Equity and Total Voting Rights
10th Apr 20177:00 amRNSIssue of Shares
31st Mar 20174:00 pmRNSIssue of Equity and Total Voting Rights
31st Mar 20177:00 amRNSIssue of Shares
27th Mar 20175:05 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
22nd Mar 20177:00 amRNSInterim Results
15th Mar 20177:00 amRNSFour-year supply agreement
7th Mar 20177:00 amRNSIssue of Shares
20th Feb 20177:00 amRNSIssue of Shares
3rd Feb 20177:01 amRNSProposed Strategic Investment
3rd Feb 20177:00 amRNSTrading update & Notice of results
16th Jan 201711:45 amRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.